DYSRUPTX LTD
Company number SC731650 · Active · Glasgow G12 8QQ
DYSRUPTX LTD is an active private limited company (company number SC731650) incorporated on 6 May 2022, registered in Glasgow. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest dormant accounts cover the period ending 31 May 2025, showing net assets of £150 and cash of £150. Net assets were unchanged on the prior period.
By net assets it sits in the lower half of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).
Key dates
- Incorporated
- 6 May 2022
- Next accounts due
- 28 February 2027 — in 131 days
- Confirmation statement due
- 20 May 2027 — in 212 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Dormant
- Size band
- Micro (Companies Act thresholds)
Financials — 2 periods on record, latest ending 31 May 2025
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 May 2025 | £150 | £150 | — | — | — | — | — |
| 31 May 2024 | £150 | £150 | — | — | — | — | — |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Firmoscan score: 64/100 (grade C)
- +10 Positive net assets — Net assets £150 at 2025-05-31
- +4 Past first filings — Incorporated 2022-05-06
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice.
Ownership and control
- Dr Connor Macleod Blair — owns 50–75% of shares; owns 50–75% of shares; holds 50–75% of voting rights; holds 50–75% of voting rights; can appoint or remove directors; can appoint or remove directors · since 12 September 2022
- Professor George Scott Baillie — owns 25–50% of shares; holds 25–50% of voting rights · since 12 September 2022
- Dr Douglas Fraser Gray — owns 25–50% of shares; holds 25–50% of voting rights · since 6 May 2022 · ceased 14 March 2025
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Similar companies in Glasgow
Same activity (research and experimental development on biotechnology), closest in incorporation date.
- DAMION CORRIGAN CONSULTING LTD — Glasgow, inc. Apr 2022
- ONCOLYTICAL LIMITED — Glasgow, inc. May 2022
- ETIVE CLINICAL DEVELOPMENT LTD — Giffnock, inc. Jan 2022
- COMPLETOMICS LIMITED — Hamilton, inc. Jan 2022
- GLEN CLOVA SCIENTIFIC LIMITED — Glasgow, inc. Sept 2022
- NAMI SURGICAL LIMITED — Glasgow, inc. Dec 2021
Reminders for DYSRUPTX LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.